These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12527799)

  • 21. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
    Yuan L; Qian S; Xiao Y; Sun H; Zeng S
    Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes.
    Barbier O; Girard C; Breton R; Bélanger A; Hum DW
    Biochemistry; 2000 Sep; 39(38):11540-52. PubMed ID: 10995221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
    Chen M; LeDuc B; Kerr S; Howe D; Williams DA
    Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of N-glycosylation on the glucuronidation of zidovudine and morphine by UGT2B7 expressed in HEK293 cells.
    Nagaoka K; Hanioka N; Ikushiro S; Yamano S; Narimatsu S
    Drug Metab Pharmacokinet; 2012; 27(4):388-97. PubMed ID: 22240840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of cytochrome P450 3A4 and UDP-glucuronosyltransferase 2B7: evidence for protein-protein association and possible involvement of CYP3A4 J-helix in the interaction.
    Takeda S; Ishii Y; Iwanaga M; Nurrochmad A; Ito Y; Mackenzie PI; Nagata K; Yamazoe Y; Oguri K; Yamada H
    Mol Pharmacol; 2009 Apr; 75(4):956-64. PubMed ID: 19158361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
    Coffman BL; Green MD; King CD; Tephly TR
    Mol Pharmacol; 1995 Jun; 47(6):1101-5. PubMed ID: 7603447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling.
    Lewis BC; Mackenzie PI; Miners JO
    Biochem Pharmacol; 2011 Dec; 82(12):2016-23. PubMed ID: 21930117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
    Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; Bélanger A
    Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.
    Ishii Y; Hansen AJ; Mackenzie PI
    Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation.
    Rowland A; Gaganis P; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
    J Pharmacol Exp Ther; 2007 Apr; 321(1):137-47. PubMed ID: 17237258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
    Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.
    Ohno S; Kawana K; Nakajin S
    Drug Metab Dispos; 2008 Apr; 36(4):688-94. PubMed ID: 18187562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the human liver UDP-glucuronosyltransferase 2B4 domains involved in the binding of UDP-glucuronic acid using photoaffinity labeling of fusion proteins.
    Pillot T; Ouzzine M; Fournel-Gigleux S; Lafaurie C; Tebbi D; Treat S; Radominska A; Lester R; Siest G; Magdalou J
    Biochem Biophys Res Commun; 1993 Dec; 197(2):785-91. PubMed ID: 8267616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the Endoplasmic Reticulum Localization of UDP-Glucuronosyltransferase 2B7 with Systematic Deletion Mutants.
    Miyauchi Y; Kimura S; Kimura A; Kurohara K; Hirota Y; Fujimoto K; Mackenzie PI; Tanaka Y; Ishii Y
    Mol Pharmacol; 2019 May; 95(5):551-562. PubMed ID: 30944207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element.
    Lu Y; Heydel JM; Li X; Bratton S; Lindblom T; Radominska-Pandya A
    Drug Metab Dispos; 2005 Jul; 33(7):937-46. PubMed ID: 15821044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode.
    Takeda S; Kitajima Y; Ishii Y; Nishimura Y; Mackenzie PI; Oguri K; Yamada H
    Drug Metab Dispos; 2006 Aug; 34(8):1277-82. PubMed ID: 16679387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
    Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
    Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.